The Latest Breaking News on Pharma

Key Takeaways: Lepu Biopharma will incur more operational costs as it builds up its production capacity and sales and marketing teams to commercialize its first approved product The company’s stock surged after it said it would list on Shanghai’s STAR Market and be included in the Shenzhen-Hong Kong Stock Connect…

The Government of India has ordered a probe after WHO issued a warning about the drugs manufactured by Haryana-based pharmaceutical firm

Covid cases are rising as winter hits, and experts predicting a “twindemic” of the virus and flu are encouraging extra vigilance. Katie Strick reports on how Londoners are tackling the situation

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."

The World Health Organization has issued a warning that four cough and cold syrups produced by Maiden Pharmaceuticals in India could be linked to the deaths of 66 children in Gambia. The UN health agency says contaminated medication may have been distributed to other countries.

WHO says medications in question may have been distributed outside The Gambia

A leading expert says sub-variants of the Omicron strain are quickly spreading.

Maiden Pharmaceutical Limited is the manufacturer licensed by the State drug controller for the products under reference, and holds manufacturing permission for these products

Clare Adamson visited Antibody Analytics, who are specialists in Primary Cell Method development and analysis; their research advances drug development.